OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/02/2025
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Descrição da marca
The mark consists of a green four leaf clover outlined in black and white. To the right of the clover is the wording "FROM DISCOVERY TO CURE" in black.
Titulares
Representantes
Patricia A. Walker Walker & Jocke Co., LPA
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 36
Monetary affairs, namely, financial planning services, accepting and administering monetary charitable contributions; charitable fundraising services, namely, collection of monetary donations for beneficent and charitable purposes; financing of research projects and clinical studies of others; administering monetary charitable contributions for destitute, socially deprived and needy people and families for the purpose of procuring and providing benefits-in-kind, financial advice and consultancy services, namely, for the benefit of people, in particular children, having rare diseases, rare genetically caused diseases, in particular of the blood and the immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel syndrome, and for the benefit of their families and relatives, in particular in emerging and developing countries and administering monetary charitable contributions for students and physicians, pharmacists and natural scientists for further education and training purposes in the field of rare diseases affecting humans
Classe 41
Educational services, namely, providing online instruction in the field of science, medicine, healthcare, hygiene and nutrition via an online website, and further training services in the field of science, hygiene, nutrition, healthcare and medicine; providing medical educational services, namely, classes, seminars and webinars in the field of hygiene, nutrition, rare diseases, rare genetically caused diseases, diseases of the blood and the immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel syndrome and related medical information; providing a website featuring non-downloadable electronic publications in the nature of books, magazines and brochures in the field of science, medicine, healthcare, hygiene, nutrition, rare diseases, rare genetically caused diseases, diseases of the blood and the immune system; educational services, namely, providing further education in the field of science via classes, seminars and workshops and organization of educational events in the field of science, medicine, healthcare, hygiene and nutrition; organization of artistic performances and art exhibitions, vernissages and finissages; publication of printed matter in electronic form except for advertising purposes, in the field of rare diseases, rare genetically caused diseases, in particular of the blood and immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel diseases affecting humans, in particular children
Classe 42
Scientific and biological research and scientific laboratory services, technological research in the field of medicine, biology, genetics, healthcare, chemistry and biochemistry and technological consulting services in the field of medical diagnosis systems and medical therapeutic systems; clinical and diagnostic research in the field of medicine and genetics, chemical, biological, genetic engineering, molecular biological and biotechnological research; genetic engineering services, conducting of clinical studies for pharmaceutical preparations, research and development services in the field of immunology, gene therapy and stem cell research; conducting scientific investigations for medical purposes; drawing up scientific expert opinions, namely, scientific, medical, clinical therapy and technical surveying; scientific research, biological, chemical and medical research; medical and scientific research featuring the development of new therapies, in particular pharmacotherapy, cell and gene therapy; basic scientific research, therapy development and research services in the field of rare diseases, rare genetically caused diseases, in particular of the blood and immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel diseases affecting humans, in particular children
Classe 44
Medical services, medical diagnostic services for testing and analysis purposes; out-patient and mobile nursing services, medical and therapeutic care, therapy consultancy for medical purposes, providing and arranging of medical care, in the field of rare diseases, rare genetically caused diseases, in particular of the blood and immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel diseases affecting humans, in particular children; medical testing for diagnostic purposes, namely, clinical, immunological, molecular biological, biochemical, chemical and genetic diagnostics in the field of rare diseases, rare genetically caused diseases, in particular of the blood and immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel diseases; psychosocial counseling
Histórico de despachos e eventos da marca no USPTO.
61 publicações encontradas
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/02/2025
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/02/2025
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
11/05/2024
REGISTERED-SEC.71 ACCEPTED
11/05/2024
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
25/03/2024
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
30/10/2023
CORRECTION TRANSACTION RECEIVED FROM IB
16/09/2023
CHANGE OF NAME/ADDRESS REC'D FROM IB
09/09/2023
TEAS SECTION 71 RECEIVED
14/07/2023
NEW REPRESENTATIVE AT IB RECEIVED
18/11/2022
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
16/07/2022
INTERNATIONAL REGISTRATION RENEWED
20/01/2022
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
23/04/2021
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
23/04/2021
NEW REPRESENTATIVE AT IB RECEIVED
21/05/2020
TEAS CHANGE OF CORRESPONDENCE RECEIVED
20/02/2020
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
20/02/2020
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
20/02/2020
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
20/02/2020
TEAS CHANGE OF OWNER ADDRESS RECEIVED
20/02/2020
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
20/02/2020
POST REGISTRATION ACTION MAILED - SEC. 71 & 15
28/12/2019
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/11/2019
TEAS SECTION 71 & 15 RECEIVED
03/10/2019
NEW REPRESENTATIVE AT IB RECEIVED
27/12/2018
NEW REPRESENTATIVE AT IB RECEIVED
21/06/2018
FINAL DECISION TRANSACTION PROCESSED BY IB
13/03/2014
FINAL DISPOSITION NOTICE SENT TO IB
25/02/2014
FINAL DISPOSITION PROCESSED
25/02/2014
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
16/10/2013
REGISTERED-PRINCIPAL REGISTER
16/07/2013
NOTIFICATION PROCESSED BY IB
01/07/2013
PUBLISHED FOR OPPOSITION
30/04/2013
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/04/2013
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/04/2013
NOTICE OF PUBLICATION
10/04/2013
LAW OFFICE PUBLICATION REVIEW COMPLETED
22/03/2013
APPROVED FOR PUB - PRINCIPAL REGISTER
18/03/2013
EXAMINERS AMENDMENT MAILED
18/03/2013
EXAMINER'S AMENDMENT ENTERED
15/03/2013
EXAMINERS AMENDMENT -WRITTEN
15/03/2013
PREVIOUS ALLOWANCE COUNT WITHDRAWN
13/03/2013
WITHDRAWN FROM PUB - OG REVIEW QUERY
10/03/2013
LAW OFFICE PUBLICATION REVIEW COMPLETED
25/02/2013
ASSIGNED TO LIE
24/02/2013
APPROVED FOR PUB - PRINCIPAL REGISTER
13/02/2013
EXAMINERS AMENDMENT MAILED
12/02/2013
EXAMINER'S AMENDMENT ENTERED
12/02/2013
EXAMINERS AMENDMENT -WRITTEN
12/02/2013
TEAS/EMAIL CORRESPONDENCE ENTERED
11/02/2013
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/02/2013
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/02/2013
REFUSAL PROCESSED BY IB
30/08/2012
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/08/2012
REFUSAL PROCESSED BY MPU
08/08/2012
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/08/2012
NON-FINAL ACTION WRITTEN
07/08/2012
APPLICATION FILING RECEIPT MAILED
07/08/2012
ASSIGNED TO EXAMINER
03/08/2012
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/08/2012
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/08/2012
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.